Miriam Méndez-Del Villar

5PUBLICATIONS
27CO-AUTHORS
Medical infection agents (incl. prions)Regenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Traditional, complementary and integrative medicine not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 27, 2025
miR-197, miR-101, and miR-143 and Pro-Inflammatory Cytokines in Migraine.

Roberto Carlos Rosales-Gómez, Beatriz Teresita Martín-Márquez, Alvaro Jovanny Tovar-Cuevas

|May 14, 2025
Genetic Variants of the ATIC Gene and Therapeutic Response to Methotrexate in Patients with Rheumatoid Arthritis.

Sergio Gabriel Gallardo-Moya, Laura Gonzalez-Lopez, Betsabe Contreras-Haro

|Oct 14, 2023
Genetic Variant HLA-DRB1*0403 and Therapeutic Response to Disease-Modifying Therapies in Multiple Sclerosis: A Case-Control Study.

Esteban Alejandro Gomez-Gaitan, Yessica Eleanet Garcia-Ortega, Ana Miriam Saldaña-Cruz

|Apr 22, 2022
Therapeutic Targets for Regulating Oxidative Damage Induced by Ischemia-Reperfusion Injury: A Study from a Pharmacological Perspective.

Walter Ángel Trujillo-Rangel, Leonel García-Valdés, Miriam Méndez-Del Villar

|Aug 24, 2017
Comment on Timmers et al. Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2016;39:2211-2217.

Miriam Méndez-Del Villar, Manuel González-Ortiz, Esperanza Martínez-Abundis

Pageof 1

Frequent Collaborators

2 joint publications

Laura Gonzalez-Lopez

2 joint publications

Alejandra Villagomez-Vega

1 joint publications

Walter Ángel Trujillo-Rangel

1 joint publications

Rolando Castañeda-Arellano